Target intelligence / Profile preview

Ribosomal protein L9 pseudogene 6 (RPL9P6)

Target
RPL9P6
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L9 pseudogene 6 (RPL9P6) is categorized as a processed pseudogene of the ribosomal protein L9 gene (RPL9)[2][5]. Pseudogenes are DNA sequences that are similar to known genes but are non-functional due to accumulated mutations (such as frameshifts or premature stop codons)[2]. RPL9P6 is one of several dispersed processed pseudogenes related to the functional RPL9 gene, which encodes an essential component of the large (60S) ribosomal subunit involved in protein synthesis[1][4][5]. However, pseudogenes like RPL9P6 do not code for active proteins, are generally not expressed, and have no established therapeutic, diagnostic, or biomarker roles. While some pseudogenes may occasionally acquire regulatory functions or be transcribed in certain contexts, there is currently no evidence that RPL9P6 is functional or relevant as a disease target or drug receptor[2][5].\n\nThe canonical functional ribosomal protein is "60S ribosomal protein L9" (RPL9), but RPL9P6 is explicitly a pseudogene and not the functional gene or protein[2][5]. The presence of multiple RPL9 pseudogenes is typical for ribosomal protein genes, reflecting evolutionary gene duplication and retrotransposition events rather than current biological or therapeutic utility[1][2][5].

Other names
RPL9_10_1398RPL9P6

Beyond the preview

Go deeper on Ribosomal protein L9 pseudogene 6 (RPL9P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L9 pseudogene 6 (RPL9P6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call